Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

4X8J

Crystal Structure of murine 12F4 Fab monoclonal antibody against ADAMTS5

Summary for 4X8J
Entry DOI10.2210/pdb4x8j/pdb
Related4X80
Descriptor12F4 FAB Light chain, 12F4 FAB Heavy chain, ZINC ION, ... (5 entities in total)
Functional Keywordsmonoclonal, immune system
Biological sourceMus musculus
More
Total number of polymer chains4
Total formula weight95543.12
Authors
Larkin, J.,Lohr, T.A.,Elefante, L.,Shearin, J.,Matico, R.,Su, J.-L.,Xue, Y.,Liu, F.,Genell, C.,Miller, R.E.,Tran, P.B.,Malfait, A.-M.,Maier, C.C.,Matheny, C.J. (deposition date: 2014-12-10, release date: 2015-04-08, Last modification date: 2024-10-09)
Primary citationLarkin, J.,Lohr, T.A.,Elefante, L.,Shearin, J.,Matico, R.,Su, J.L.,Xue, Y.,Liu, F.,Genell, C.,Miller, R.E.,Tran, P.B.,Malfait, A.M.,Maier, C.C.,Matheny, C.J.
Translational development of an ADAMTS-5 antibody for osteoarthritis disease modification.
Osteoarthr. Cartil., 23:1254-1266, 2015
Cited by
PubMed Abstract: Aggrecanase activity, most notably ADAMTS-5, is implicated in pathogenic cartilage degradation. Selective monoclonal antibodies (mAbs) to both ADAMTS-5 and ADAMTS-4 were generated and in vitro, ex vivo and in vivo systems were utilized to assess target engagement, aggrecanase inhibition and modulation of disease-related endpoints with the intent of selecting a candidate for clinical development in osteoarthritis (OA).
PubMed: 25800415
DOI: 10.1016/j.joca.2015.02.778
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (2.35 Å)
Structure validation

237735

数据于2025-06-18公开中

PDB statisticsPDBj update infoContact PDBjnumon